Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Prevail Global Study

NCT: NCT06535854 · RECRUITING

NCT IDNCT06535854
StatusRECRUITING
Start Date2025-02-24
Completion2031-02

Brief Summary

The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB.

Frequently Asked Questions

What is Prevail Global Study?

Prevail Global Study is a clinical trial registered under NCT06535854. Current status: RECRUITING.

What is the status of NCT06535854?

The current status of NCT06535854 (Prevail Global Study) is: RECRUITING.

When did Prevail Global Study start?

Prevail Global Study started on 2025-02-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑